Wednesday, October 23, 2024

Understanding Stereotactic Breast Biopsy: Procedure, Risks, and Results

The recent advancement in medical technology has made early detection of breast cancer easier than ever before. One such procedure that plays a crucial role in diagnosing breast abnormalities is a stereotactic breast biopsy.

A stereotactic breast biopsy is a procedure recommended by healthcare providers when abnormal results are found in other breast imaging tests like mammograms, ultrasounds, or MRI scans. This biopsy helps in accurately locating and removing tissue from suspicious areas in the breast to rule out or diagnose breast cancer.

There are two main types of stereotactic breast biopsy procedures: core needle biopsy and vacuum-assisted biopsy. Both procedures are minimally invasive and use mammography and computer guidance to precisely locate and sample the suspicious area.

During the test, patients lie down on a special table while the healthcare team compresses the breast between two plates to immobilize it for accurate imaging and biopsy. The procedure typically lasts about an hour, with the imaging and biopsy portions being conducted consecutively.

After the test, patients are advised to avoid strenuous activities and are encouraged to use ice packs to reduce swelling and bruising. The biopsy site is compressed and bandaged to minimize bleeding, and patients are monitored for any immediate side effects or complications.

While a stereotactic breast biopsy is generally safe, there are some rare risks and complications associated with the procedure, such as bleeding at the biopsy site or a skin infection. However, the benefits of early detection far outweigh these risks.

Once the tissue sample is sent to the lab, a pathologist examines the biopsied tissue to make the final diagnosis. Results can be positive (cancer is present), negative (no cancer found), or inconclusive (uncertain diagnosis).

In conclusion, a stereotactic breast biopsy is a valuable tool in the early detection and diagnosis of breast abnormalities. Patients can expect to receive their results within a week and, based on these results, healthcare providers can recommend appropriate treatment, further testing, or monitoring. With advancements in medical technology, procedures like stereotactic breast biopsies are helping save lives by detecting breast cancer at an early stage.

Related Articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest Articles